T50.2X5 is a non-billable/non-specific diagnosis code from the 2025 ICD-10-CM used to classify the following condition: Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics.
Codes
T50.2X5A
Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter
T50.2X5D
Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, subsequent encounter
T50.2X5S
Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela
Versions
2025
No changes
2024
No changes
2023
No changes
2022
No changes
2021
No changes
2020
No changes
2019
No changes
2018
No changes
2017
No changes
2016
New code